Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol vs bisoprolol in mild to moderate primary hypertension
CTR20160212Phase 2Completed
- Sponsor
- Synlead Pharmaceutical
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nebivolol in essential hypertension, sponsored by Synlead Pharmaceutical. Started Apr 2016; status: completed.
02
Drugs
nebivolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20160212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160212.